Double maintains 2 strategies that include ELVN - Enliven Therapeutics, Inc.
Current Value
$22.531 Year Return
Current Value
$22.531 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GSST | 0.04% | $920.88M | 0.16% |
| SHM | 0.08% | $3.41B | 0.2% |
| HYD | 0.11% | $3.31B | 0.32% |
| IYK | 0.18% | $1.44B | 0.4% |
| SPMB | -0.19% | $6.15B | 0.04% |
| UITB | 0.31% | $2.33B | 0.39% |
| VTEB | -0.38% | $37.74B | 0.03% |
| TDTT | 0.41% | $2.63B | 0.18% |
| GNMA | 0.42% | $373.80M | 0.1% |
| MMIT | -0.44% | $1.03B | 0.3% |
| IBTF | -0.57% | $1.98B | 0.07% |
| GOVI | -0.59% | $929.67M | 0.15% |
| USDU | -0.64% | $129.80M | 0.5% |
| TOTL | -0.65% | $3.80B | 0.55% |
| VTIP | -0.65% | $15.15B | 0.03% |
| ISTB | -0.67% | $4.41B | 0.06% |
| BILZ | 0.71% | $851.85M | 0.14% |
| SHYD | 0.77% | $331.91M | 0.35% |
| CGCB | -0.78% | $2.51B | 0.27% |
| AGGH | -0.78% | $321.29M | 0.29% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CME | -17.93% | $99.17B | +44.04% | 1.75% |
| CBOE | -17.61% | $24.55B | +38.09% | 1.08% |
| MO | -12.07% | $98.62B | +24.36% | 7.00% |
| ED | -11.81% | $36.42B | +10.51% | 3.36% |
| K | -11.51% | $27.64B | +40.17% | 2.86% |
| CL | -10.14% | $73.44B | -7.30% | 2.25% |
| KMB | -9.17% | $43.78B | -6.43% | 3.77% |
| UNH | -8.22% | $271.70B | -40.62% | 2.85% |
| KO | -7.98% | $300.31B | +10.57% | 2.87% |
| COR | -7.63% | $57.63B | +33.93% | 0.73% |
| MCK | -7.50% | $89.25B | +24.22% | 0.40% |
| DFDV | -7.15% | $363.21M | +2,422.23% | 0.00% |
| KR | -6.92% | $46.75B | +34.05% | 1.81% |
| AWK | -6.76% | $27.82B | +4.74% | 2.18% |
| ELV | -6.73% | $78.14B | -35.21% | 1.95% |
| ALHC | -6.41% | $2.65B | +51.87% | 0.00% |
| CI | -5.58% | $82.49B | -7.43% | 1.90% |
| AEP | -5.39% | $56.65B | +16.73% | 3.49% |
| CHD | -4.98% | $24.40B | -4.48% | 1.17% |
| T | -4.59% | $198.74B | +46.45% | 5.06% |
Finnhub
Enliven Therapeutics, Inc. dropped from Russell 3000E Value Index...
Finnhub
Enliven Therapeutics, Inc. dropped from Russell 3000 Value Index...
Finnhub
Enliven Therapeutics, Inc. dropped from Russell 2500 Value Index...
Finnhub
Enliven Therapeutics, Inc. dropped from Russell Small Cap Comp Value Index...
Finnhub
Enliven Therapeutics, Inc. dropped from Russell 2000 Value Index...
Finnhub
Enliven Therapeutics, Inc. dropped from Russell Microcap Value Index...
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 57.37% | $4.81B | 0.35% |
| GNOM | 52.16% | $46.47M | 0.5% |
| IBB | 51.37% | $5.37B | 0.45% |
| ARKG | 50.95% | $1.03B | 0.75% |
| PBE | 47.04% | $226.91M | 0.58% |
| IWC | 46.58% | $840.86M | 0.6% |
| IWO | 46.24% | $11.77B | 0.24% |
| PTH | 44.68% | $96.25M | 0.6% |
| VTWO | 44.56% | $12.65B | 0.07% |
| IWM | 44.54% | $65.64B | 0.19% |
| ISCG | 44.54% | $688.57M | 0.06% |
| ARKK | 44.48% | $6.81B | 0.75% |
| VBK | 44.35% | $19.19B | 0.07% |
| PINK | 44.21% | $130.30M | 0.5% |
| SCHA | 44.08% | $17.61B | 0.04% |
| METV | 44.01% | $301.64M | 0.59% |
| KOMP | 43.98% | $2.34B | 0.2% |
| KJAN | 43.92% | $279.50M | 0.79% |
| KJUL | 43.86% | $159.39M | 0.79% |
| ULTY | 43.63% | $961.00M | 1.3% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DNLI | 49.93% | $2.23B | -33.52% | 0.00% |
| SYRE | 48.93% | $963.24M | -43.26% | 0.00% |
| CRNX | 47.95% | $3.00B | -39.42% | 0.00% |
| XNCR | 47.34% | $660.47M | -52.14% | 0.00% |
| NRIX | 46.90% | $965.91M | -42.49% | 0.00% |
| OCUL | 46.89% | $1.77B | +45.79% | 0.00% |
| APGE | 45.99% | $2.30B | -16.02% | 0.00% |
| ZYME | 45.30% | $959.66M | +38.40% | 0.00% |
| RVMD | 44.95% | $7.17B | -11.19% | 0.00% |
| DAWN | 44.22% | $728.79M | -52.38% | 0.00% |
| BHVN | 44.20% | $1.53B | -60.40% | 0.00% |
| EYPT | 44.11% | $761.06M | +11.60% | 0.00% |
| AGIO | 43.62% | $2.29B | -10.95% | 0.00% |
| KYMR | 43.13% | $3.17B | +15.92% | 0.00% |
| ATXS | 43.02% | $376.42M | -40.71% | 0.00% |
| ARCT | 43.02% | $392.71M | -39.06% | 0.00% |
| NNOX | 43.01% | $330.29M | -39.09% | 0.00% |
| KRYS | 42.85% | $4.33B | -24.53% | 0.00% |
| DYN | 42.77% | $1.25B | -79.03% | 0.00% |
| IDYA | 42.70% | $2.00B | -42.45% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| PRPO | 0.01% | $23.73M | +229.04% | 0.00% |
| MCD | 0.02% | $213.36B | +17.11% | 2.34% |
| HRL | 0.06% | $17.34B | +2.17% | 3.65% |
| PM | 0.06% | $281.71B | +72.37% | 3.01% |
| KDP | 0.10% | $45.70B | +3.76% | 2.75% |
| FATBB | 0.13% | $47.76M | -9.82% | 10.45% |
| MSIF | 0.16% | $773.71M | +36.92% | 7.56% |
| CPB | 0.21% | $9.09B | -32.74% | 5.09% |
| LFVN | 0.23% | $155.72M | +105.82% | 1.34% |
| CPSH | 0.23% | $36.02M | +47.62% | 0.00% |
| WTRG | -0.25% | $10.52B | -6.15% | 3.49% |
| SJM | 0.28% | $11.17B | -5.83% | 4.17% |
| COKE | 0.28% | $8.92B | +5.67% | 7.02% |
| AGI | -0.29% | $10.98B | +49.03% | 0.38% |
| MOH | -0.41% | $12.39B | -21.20% | 0.00% |
| MKTX | -0.44% | $8.21B | +2.36% | 1.37% |
| IMNN | -0.45% | $13.21M | -54.55% | 0.00% |
| PPC | -0.48% | $10.64B | +33.60% | 0.00% |
| MDLZ | -0.49% | $86.95B | +2.80% | 2.82% |
| CTRE | 0.52% | $5.87B | +17.71% | 4.08% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -36.98% | $94.86M | 0.59% |
| BTAL | -35.93% | $315.93M | 1.43% |
| VIXY | -35.86% | $184.73M | 0.85% |
| XONE | -20.73% | $628.85M | 0.03% |
| IVOL | -18.20% | $342.69M | 1.02% |
| SPTS | -17.91% | $5.77B | 0.03% |
| ULST | -16.45% | $592.38M | 0.2% |
| FTSD | -16.23% | $233.11M | 0.25% |
| IBTG | -15.36% | $1.92B | 0.07% |
| UTWO | -14.93% | $376.33M | 0.15% |
| SHYM | -14.79% | $355.86M | 0.35% |
| VGSH | -13.00% | $22.68B | 0.03% |
| FXY | -12.72% | $802.69M | 0.4% |
| IBTH | -12.36% | $1.62B | 0.07% |
| XHLF | -12.10% | $1.73B | 0.03% |
| BSMW | -11.87% | $107.49M | 0.18% |
| SCHO | -11.86% | $10.98B | 0.03% |
| IBTI | -10.67% | $1.06B | 0.07% |
| LDUR | -9.45% | $922.12M | 0.5% |
| SHY | -8.65% | $23.54B | 0.15% |
